International Journal of Endocrinology and Metabolism

Published by: Kowsar

Can Procalcitonin Be an Accurate Diagnostic Marker for the Classification of Diabetic Foot Ulcers?

Nematollah Jonaidi Jafari 1 , Mahdi Safaee Firouzabadi 1 , Morteza Izadi 1 , Mohammad Sadegh Safaee Firouzabadi 2 and Amin Saburi 3 , 4 , *
Authors Information
1 Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Department of Clinical Sciences, School of Veterinary Medicine, Ardakan University, Ardakan, IR Iran
3 Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
4 Atherosclerosis and Coronary Artery Research Centre, Birjand University of Medical Sciences, Birjand, IR Iran
Article information
  • International Journal of Endocrinology and Metabolism: January 01, 2014, 12 (1); e13376
  • Published Online: January 1, 2014
  • Article Type: Research Article
  • Received: July 14, 2013
  • Revised: September 4, 2013
  • Accepted: October 14, 2013
  • DOI: 10.5812/ijem.13376

To Cite: Jonaidi Jafari N, Safaee Firouzabadi M, Izadi M, Safaee Firouzabadi M S, Saburi A. et al. Can Procalcitonin Be an Accurate Diagnostic Marker for the Classification of Diabetic Foot Ulcers?, Int J Endocrinol Metab. 2014 ;12(1):e13376. doi: 10.5812/ijem.13376.

Abstract
Copyright: Copyright © 2014, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, et al. Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care. 2004; 27(7): 1591-7[PubMed]
  • 2. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999; 22(3): 382-7[PubMed]
  • 3. Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008; 31(8): 1679-85[DOI][PubMed]
  • 4. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990; 13(5): 513-21[PubMed]
  • 5. Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev. 2004; 20 Suppl 1-5[DOI][PubMed]
  • 6. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA. 1995; 273(9): 721-3[PubMed]
  • 7. Neal LW, Wagner FW. The Diabetic Foot. 1983;
  • 8. Pozzilli P, Leslie RD. Infections and diabetes: mechanisms and prospects for prevention. Diabet Med. 1994; 11(10): 935-41[PubMed]
  • 9. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004; 39(7): 885-910[DOI][PubMed]
  • 10. Arnon S, Litmanovitz I. Diagnostic tests in neonatal sepsis. Curr Opin Infect Dis. 2008; 21(3): 223-7[DOI][PubMed]
  • 11. Christ-Crain M, Schuetz P, Huber AR, Muller B. [Procalcitonin - importance for the diagnosis of bacterial infections]. Ther Umsch. 2008; 65(9): 559-68[DOI][PubMed]
  • 12. Ertugrul BM, Savk O, Ozturk B, Cobanoglu M, Oncu S, Sakarya S. The diagnosis of diabetic foot osteomyelitis: examination findings and laboratory values. Med Sci Monit. 2009; 15(6)-12[PubMed]
  • 13. Hunziker S, Hugle T, Schuchardt K, Groeschl I, Schuetz P, Mueller B, et al. The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery. J Bone Joint Surg Am. 2010; 92(1): 138-48[DOI][PubMed]
  • 14. Jeandrot A, Richard JL, Combescure C, Jourdan N, Finge S, Rodier M, et al. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia. 2008; 51(2): 347-52[DOI][PubMed]
  • 15. Maniaci V, Dauber A, Weiss S, Nylen E, Becker KL, Bachur R. Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics. 2008; 122(4): 701-10[DOI][PubMed]
  • 16. Ruiz-Alvarez MJ, Garcia-Valdecasas S, De Pablo R, Sanchez Garcia M, Coca C, Groeneveld TW, et al. Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis. J Intensive Care Med. 2009; 24(1): 63-71[DOI][PubMed]
  • 17. Uzun G, Solmazgul E, Curuksulu H, Turhan V, Ardic N, Top C, et al. Procalcitonin as a diagnostic aid in diabetic foot infections. Tohoku J Exp Med. 2007; 213(4): 305-12[PubMed]
  • 18. Williams DT, Hilton JR, Harding KG. Diagnosing foot infection in diabetes. Clin Infect Dis. 2004; 39 Suppl 2-6[DOI][PubMed]
  • 19. Balc IC, Sungurtekin H, Gurses E, Sungurtekin U, Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care. 2003; 7(1): 85-90[PubMed]
  • 20. Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004; 8(4)-42[DOI][PubMed]
  • 21. Fottner A, Birkenmaier C, von Schulze Pellengahr C, Wegener B, Jansson V. Can serum procalcitonin help to differentiate between septic and nonseptic arthritis? Arthroscopy. 2008; 24(2): 229-33[DOI][PubMed]
  • 22. Christ-Crain M, Muller B. Procalcitonin in bacterial infections--hype, hope, more or less? Swiss Med Wkly. 2005; 135(31-32): 451-60[PubMed]
  • 23. Hladik M, Olosova A, Neiser J, Zaoral T. Procalcitonin--a marker and mediator of inflammation. Acta Chir Plast. 2005; 47(2): 51-4[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader